Cooper Companies | Ativo Circulante



Current Assets Alterar Data
Abbott USD 24.47B 1.32B 2025-06
Align Technology USD 2.45B 46.03M 2025-06
AtriCure USD 271.26M 19.77M 2025-06
Avanos Medical USD 356M 3.6M 2025-06
Bausch Health Companies USD 6.51B 782M 2025-06
Baxter International USD 7.04B 1.82B 2025-03
Bayer EUR 33.75B 1.08B 2025-06
Becton, Dickinson and Co. USD 9B 331M 2025-06
Boston Scientific USD 7.34B 415M 2025-03
Cooper Companies USD 2.14B 12.1M 2025-07
Dentsply International USD 1.97B 12M 2025-06
Dexcom USD 5.03B 476.4M 2025-06
Edwards Lifesciences USD 6.21B 72.7M 2025-03
Globus Medical USD 1.73B 19.79M 2025-06
Haemonetics USD 913.16M 21.82M 2025-06
Hologic USD 3.42B 212.7M 2025-06
Insulet USD 2.28B 48.7M 2025-06
Integra LifeSciences USD 1.14B 35.58M 2025-06
Intuitive Surgical USD 12.47B 592.4M 2025-06
J&J USD 71.55B 15.66B 2025-03
Medtronic USD 23.81B 1.3B 2025-04
Merit Medical Systems USD 923.07M 35.56M 2025-06
Novartis USD 25.94B 3.76B 2025-06
ResMed USD 3.51B 297.18M 2025-06
STAAR Surgical USD 292.79M 33.71M 2025-06
Steris USD 2.06B 57.04M 2025-06
Stryker USD 13B 19M 2025-06
Tandem Diabetes Care USD 614.82M 48.62M 2025-06
Teleflex USD 1.72B 184.95M 2025-06
Zimmer Biomet Holdings USD 5.05B 536.3M 2025-06


Cooper Companies Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Sep 2025.